


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









﻿





Scottbrand - Error handling- 500 page


































Unexpected Error

                                        It looks like our system hit the sheets early and wasn't

                                        able to complete your request.
                                        Please try again.
                                    
RETURN TO THE HOMEPAGE


















R. Scott Greer - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















R. Scott Greer
Board Member at Nektar Therapeutics


View Full Profile
Are you R. Scott Greer? Claim your profile


 


Sign up for Equilar Atlas and view R. Scott Greer's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in R. Scott Greer's  network and community.
												FOLLOW changes in R. Scott Greer's employment and money-in-motion.
												CONNECT with R. Scott Greer through your network of contacts.
												








R. Scott Greer's Executive Work History


Current


Board Member, 
Nektar Therapeutics


Past
To view R. Scott Greer's complete executive work history, sign up now
Age
58

 
 


R. Scott Greer's Biography



R. Scott Greer, age 58, has served as our director since February 2010. Mr. Greer currently serves as Managing Director of Numenor Ventures, LLC, a venture capital firm, and as the Chairman of the Board of Calimmune, Inc., a gene therapy company. In 1996, Mr. Greer co-founded Abgenix, Inc., a company that specialized in the discovery, development and manufacture of human therapeutic antibodies, and from June 1996 through May 2002, he served as its Chief Executive Officer. He also served as a director of Abgenix from 1996 and Chairman of the board of directors from 2000 until the acquisition of Abgenix by Amgen, Inc. in April 2006. Prior to Ab ...
(Read More)

			R. Scott Greer, age 58, has served as our director since February 2010. Mr. Greer currently serves as Managing Director of Numenor Ventures, LLC, a venture capital firm, and as the Chairman of the Board of Calimmune, Inc., a gene therapy company. In 1996, Mr. Greer co-founded Abgenix, Inc., a company that specialized in the discovery, development and manufacture of human therapeutic antibodies, and from June 1996 through May 2002, he served as its Chief Executive Officer. He also served as a director of Abgenix from 1996 and Chairman of the board of directors from 2000 until the acquisition of Abgenix by Amgen, Inc. in April 2006. Prior to Abgenix's formation, Mr. Greer held senior management positions at Cell Genesys, Inc., a biotechnology company, initially as Chief Financial Officer and Vice President of Corporate Development and later as Senior Vice President of Corporate Development, and various positions at Genetics Institute, Inc., a biotechnology research and development company. Mr. Greer currently serves as a member of the board of directors of Inogen, Inc., a medical device company that develops and markets oxygen therapy products, Sientra, Inc. a medical aesthetics company and Versartis, Inc., an endocrine focused biopharmaceutical company. Mr. Greer served as a member of the board of directors of Sirna Therapeutics, Inc., a biotechnology company, from 2003, and as its Chairman of the board of directors from 2005 through the closing of the acquisition of Sirna by Merck & Co., Inc. in December 2006. From May 2014 to May 2015, Mr. Greer served as director of Auspex Pharmaceuticals, a biopharmaceutical company developing drugs for patients with movement disorders and other rare diseases, which was acquired by Teva Pharmaceutical Industries in May 2015; from 2001 to 2005, he served as a member of the board of directors of Illumina, Inc., a provider of integrated systems for the analysis of genetic variation and biological function; and from 2001 to 2004, he served as member of the board of directors of CV Therapeutics, Inc., a biotechnology company. Mr. Greer also served as a member of the board of directors of StemCells, Inc., a biopharmaceutical company focused on stem cell therapeutics from 2010 to 2016. Mr. Greer received a B.A. in Economics from Whitman College and an M.B.A. degree from Harvard University. He also was a certified public accountant.
		
Source: Nektar Therapeutics on 05/01/2017
		
	

 






Sign up for Equilar Atlas and view R. Scott Greer's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like R. Scott Greer. More specifically, you'll be able to:
												

IDENTIFY corporate executives in R. Scott Greer's  network and community.
												FOLLOW changes in R. Scott Greer's employment and money-in-motion.
												CONNECT with R. Scott Greer through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: R. Scott Greer


















R. Scott Greer's Connections (132)





Sign up now to view R. Scott Greer's 132 connections »









Gisela M. Schwab
President, Product Development and Medical Affairs and Chief Medical Officer, Exelixis, Inc.









Gil M. Labrucherie
Senior Vice President and Chief Financial Officer, Nektar Therapeutics









Roger M. Perlmutter
Exe V-P & Pres, MRL, Merck & Co., Inc.









Phillip M. Schneider
Former Senior Vice President and Chief Financial Officer, Biogen Inc.









Raju S. Kucherlapati
Former Board Member, AVEO Pharmaceuticals, Inc.









Peter B. Hutt
Former Board Member, XOMA Corporation









William R. Ringo
Board Member, Immune Design Corp.









Maninder Hora
Senior Vice President, Pharmaceutical Development and Manufacturing Operations, Nektar Therapeutics









Dennis L. Winger
Board Member, Accuray Incorporated









Barbara J. McNeil
Former Board Member, Edwards Lifesciences Corporation








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Jan Koum
Board Member, Facebook, Inc.









Philip L. Milstein
Board Member, The Marcus Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993



















Greer, R. Scott - The Wall Street Transcript














































 





































R. Scott Greer
R. SCOTT GREER has served as Chairman, President and Chief Executive
Officer of Abgenix, Inc., since March 2000. From July 1996 to March
2000, Mr. Greer served as President and Chief Executive Officer and as a
Director of Abgenix. From July 1994 to July 1996, Mr. Greer was Senior
Vice President of Corporate Development at Cell Genesys, a biotechnology
company. From April 1991 to July 1994, Mr. Greer was Vice President of
Corporate Development and from April 1991 to September 1993 was also
Chief Financial Officer of Cell Genesys. From 1986 to 1991, Mr. Greer
held various positions including Director, Corporate Development, at
Genetics Institute, Inc., a biotechnology company. Mr. Greer received a
BA in Economics from Whitman College and an MBA from Harvard University
and is a Certified Public Accountant.
Related Interviews:R.scott Greer - Abgenix Inc (abgx)May 07, 2001R. Scott Greer - Abgenix Inc (abgx)January 10, 2001R.scott Greer - Abgenix Inc (abgx)October 05, 2000R. Scott Greer -  Abgenix Inc (abgx)August 14, 2000R. Scott Greer -  Abgenix Inc (abgx)November 01, 1999







CartLatest NewsJames Abate of Centre Asset Management Sees Consumer Demand Driving New Stock HighsMalcolm E. Polley of Stewart Capital and How to Play the Health Care StocksTimothy Biltz, CEO of Lumos Networks Identifies the Key Component for Future 5G NetworksThe Wall Street Transcript is a completely unique resource for investors and business researchers.Over 20,000 CEO, Equity Analyst and Money Manager InterviewsSubscribe now!Sign Up For Newsletter Weekly email with New In-Depth Interviews


Email: 



Most Popular InterviewsDelivering Long-Term Results with a Risk-Managed Growth FundJames A. Abate Published July 20, 2017 in Investing StrategiesCompanies covered: AMAT JNJ COH RL COG NVDA ADBE ATVI KLAC AMZN NFLX GOOG FB GLW MU 005930 000660 WFM JWN CMG GPS EQT RICE SPLS Buy ($25)Finding Investments with Favorable Risk and Reward OpportunitiesHenry  Beukema Published July 19, 2017 in Investing StrategiesCompanies covered: ORCL MSFT NSRGY AMZN WFM LRLCY AGN LNR Buy ($25)Better Returns and Lower Risk in the Midcap SpaceMalcolm E. Polley Published July 18, 2017 in Investing StrategiesCompanies covered: PRAA HURN FII FL NKE AMZN WFM WBA RAD Buy ($25)Most Popular ReportsWireless Communications & Telecom Published July 14, 2017Buy ($175)Investing Strategies Published July 11, 2017Buy ($175)Investing Strategies Published June 30, 2017Buy ($175) 






Top Company Interviews






Register for a Free Account to gain greater access to
            The Wall Street Transcript right now




CEO INTERVIEWSInterview with the President and CEO: Lumos Networks Corp. (NASDAQ:LMOS)Interview with the Corporate VP of Business Development, Strategy and Investor Relations: DSP Group, Inc. (NASDAQ:DSPG)Interview with the CEO and Director: Tactile Systems Technology, Inc. (NASDAQ:TCMD) 

SECTOR ROUNDTABLESNatural Gas Weighs Heavy On E&P Near-Term ProspectsRoundtable Forum:optimism Despite Uncertainty In For-profit EducationRoundtable Forum:a Shift In Focus To Natural Gas From Oil 

MONEY MANAGER INTERVIEWSDelivering Long-Term Results with a Risk-Managed Growth FundFinding Investments with Favorable Risk and Reward OpportunitiesBetter Returns and Lower Risk in the Midcap Space 

ANALYST INTERVIEWSAnalyzing the Secular Drivers Within Communications Infrastructure and TelecomSatellite Companies Benefiting from Growth in Data TrafficIncreased Focus on Content as Consumers Shift to Digital Consumption 




Subscribe Today!







                Since 1963
                © The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy  
            





https://www.twst.com/wp-admin/admin-ajax.php

Pin It on Pinterest





































Share This





Twitter





Facebook





Google+





Gmail





LinkedIn








































×





Join now for free!
Already a member?






First Name 





Last Name 





Email address *








Create new account
 


or create an account with a social network.

Join with Facebook


Join with Twitter


Join with Google








Username or Email address: *





Password: *






LoginJoin now! | Forgot password?
 


or login using a social network


Log in with Facebook


Log in with Twitter


Log in with Google












 


R. Scott Greer | Professional Profile
 


























 









LinkedIn



















































Main content starts below.




R. Scott GreerChairman of the Board at Calimmune, IncLocationParadise Valley, ArizonaIndustryVenture Capital & Private EquityCurrentCalimmune, Inc, Inogen, Inc., Versartis, Inc.PreviousStemCells, Inc., Ablexis, LLC, Auspex Pharmaceuticals, Inc.EducationHarvard Business SchoolWebsitesCompany Website500+ connectionsView R. Scott’s full profile. It's free!Your colleagues, classmates, and 500 million other professionals are on LinkedIn.View R. Scott’s Full ProfileR. Scott’s ActivityAre you a Procore Pro who is passionate about the...R. Scott likedSummaryOver 30 years of entrepreneurial experience in Life Sciences, technology and innovation driven companies. Now providing funding and advisory services to Founder/CEOs through consulting and board directorships.ExperienceChairman of the BoardCalimmune, IncJuly 2015  –  Present (2 years 1 month)Tucson, Arizona AreaDirectorInogen, Inc.August 2015  –  Present (2 years)DirectorVersartis, Inc.December 2014  –  Present (2 years 8 months)DirectorSientraJuly 2014  –  Present (3 years 1 month)Santa Barbara, California AreaManaging DirectorNumenor Ventures, LLC2002  –  Present (15 years)Invest in exciting private companies, assist CEOs and founders, and serve on corporate boards.DirectorNektar Therapeutics2010  –  Present (7 years)San Francisco Bay AreaDirectorStemCells, Inc.2010  –  August 2016 (6 years)San Francisco Bay AreaChairman of the BoardAblexis, LLC2010  –  January 2015 (5 years)San Francisco Bay AreaDirectorAuspex Pharmaceuticals, Inc.2014  –  2015 (1 year)DirectorBAROnova, Inc.2009  –  2013 (4 years)Santa Barbara, California AreaChairman of the BoardSirna Therapeutics2007  –  2009 (2 years)San Francisco Bay AreaDirectorAnaptysBio2007  –  2008 (1 year)Greater San Diego AreaChairman of the BoardInogen2005  –  2007 (2 years)Santa Barbara, California AreaCEO and ChairmanAbgenix1996  –  2007 (11 years)San Francisco Bay AreaDirectorSanta Barbara Maritime Museum2003  –  2006 (3 years)Santa Barbara, California AreaDirectorAffymax2000  –  2004 (4 years)San Francisco Bay AreaDirectorIllumina2000  –  2004 (4 years)Greater San Diego AreaSenior VP Corporate Development and CFOCell Genesys1991  –  1996 (5 years)Director, Corporate DevelopmentGenetics Institute, Inc1985  –  1991 (6 years)Greater Boston AreaAssociateBooz Allen Hamilton1983  –  1985 (2 years)Greater Chicago AreaManagerPwC1981  –  1983 (2 years)Phoenix, Arizona AreaVolunteer Experience & CausesDirectorSanta Barbara Maritime MuseumJanuary 2004  –  January 2007 (3 years 1 month)Arts and CultureSkillsLifesciencesEntrepreneurshipBiotechnologyVenture CapitalStart-upsPharmaceutical IndustryCommercializationStrategyDrug DiscoveryClinical DevelopmentMergers & AcquisitionsCorporate DevelopmentFDAImmunologyManagementSee 17+OncologyBiopharmaceuticalsTechnology TransferStrategic PartnershipsDue DiligenceR&DStrategic PlanningLicensingMedical DevicesMergersDrug DevelopmentMolecular BiologyLife SciencesBusiness StrategyConsultingBusiness DevelopmentExecutive ManagementSee lessHow's this translation?Great•Has errorsThanks for your help!EducationHarvard Business SchoolMaster of Business Administration (MBA), Strategy and EntrepreneurshipMaster of Business Administration (MBA), Strategy and Entrepreneurship1983  –  1985Activities and Societies: VP, Venture Capital ClubWhitman CollegeBachelor's degree, EconomicsBachelor's degree, Economics1977  –  1981Stadium High School1974  –  1977GroupsArizona BioIndustry Association (AZBio)Harvard Business School Alumni (Official)Professionals in the Pharmaceutical and Biotech IndustryView R. Scott’s full profile to...See who you know in commonGet introducedContact R. Scott directlyView R. Scott’s Full ProfileView this profile in another languageEnglishGermanPeople Also ViewedPatrick F. WilliamsChief Financial Officer Sientra, Board Member Miramar LabsMike PaganoPlastic Surgery Consultant at Sientra, Inc.Stefani (Walton) HudmanPlastic Surgery Consultant at SientraAmy MarieSales Experience Representative at Sientra, Inc.Mike Myersplastic surgery consultant at Sientra, Inc.Sandra RoosPlastic Surgery Business Consultant at Sientra, Inc.Mark SmithChief Financial Officer at Calimmune, IncJulie LibertiniPlastic Surgery Consultant at SientraMargie RoseRegulatory AffairsRenee GaetaChief Financial Officer at Establishment LabsPublic profile badgeInclude this LinkedIn profile on other websitesView profile badgesSearch by nameOver 500 million professionals are already on LinkedIn. Find who you know.First NameLast NameExample:  Jeff WeinerLinkedIn member directory:abcdefghijklmnopqrstuvwxyzmoreBrowse members by country




















 


Scott Greer
 | LinkedIn
 


























 









LinkedIn



















































Main content starts below.




Scott GreerArt / Creative Direction, Graphic Design / Product DesignLocationSan Francisco Bay AreaIndustryDesignCurrentGreer DesignPreviousLevi Strauss & Co.EducationCalifornia State University-ChicoWebsitesCompany Website174 connectionsView Scott’s full profile. It's free!Your colleagues, classmates, and 500 million other professionals are on LinkedIn.View Scott’s Full ProfileSummaryCreative Consulting/Direction, Art Direction, Graphic Design, Product DesignExperienceCreative ServicesGreer Design1995  –  Present (22 years)Creative Direction, Corporate Identity, Branding, Marketing Materials, Packaging, Catalog, Print Design, Logo Design, Business SystemsClient List:Levi Strauss & Co.White Sierra Clothing / InversionTimbuk2 DesignsBond GardenJetSet BeveragesSan Francisco Mental Health AssociationMiCore SolutionsEaster SealsBebeTurbo ProductionsOverland EquipmentSumo CasesMobile EdgeStreamline CircuitsTrilogy Financial ServicesRed EnvelopePet Haven ProductsSource SurgicalBank of the WestQ SurgicalACME NoveltiesPirtekGraphite Sales & MarketingGolf MonkeyGraphic SportswearWired CommunicationsTafapolski & SmithMcCown & EvansOldCastle Precast SolutionsStrategic Acquisition AdvisorsBeyond ChiropracticGraphic Designer / ContractLevi Strauss & Co.1994  –  1998 (4 years)Marketing Materials, Clothing Graphics, T-Shirt Designs, Label DesignProjectsOoboo Designs - Product Design, Creative, Marketing / OwnerStarting June 2010Product Design & Manufacturing, Marketing, PackagingProduct manufacturing of consumer goods for the pet industry.Team members: Scott GreerDignity, Recovery & Empowerment - San Francisco Mental Health AssociationStarting June 2013San FranciscoBranding / Logo Design, Brochure DesignTeam members: Scott GreerHGTV DIY "I Want That" Pet Haven VideoOctober 2012  –  November 2012Here is a national TV show on HGTV called "I Want That" that featured the Ooboo Designs - Pet Haven (Ooboo Designs)Team members: Scott GreerSumo Cases (Mobile Edge Company) - Art Director / Marketing / PartnerJanuary 2007  –  February 2010San FranciscoBrand Identity/Logo Design, Packaging, Marketing MaterialsTeam members: Scott Greer, Jim Hart, Geoff SaccoOverland Equipment - Graphic Design / Creative Consulting / ContractJanuary 2007  –  January 2009San FranciscoPackaging, Marketing Materials, Catalog DesignTeam members: Scott Greer, Mike ValvanoBond Manufacturing - Sr. Graphic Designer / ContractJanuary 2006  –  January 2008Bay Point, Ca.Packaging, Marketing Materials, Point of Purchase, Catalog Design, Brochure DesignTeam members: Scott GreerTimbuk2 Designs - Sr. Graphic Designer - Art Direction / ContractJanuary 2004  –  January 2007San FranciscoPackaging, Marketing Materials, Catalog Design, POP Design, Product GraphicsTeam members: Scott GreerWhite Sierra Clothing - Sr. Graphic Designer / ContractJanuary 2002  –  January 2006Marketing Materials, Catalog Design, Point of Purchase, Clothing GraphicsTeam members: Scott Greer, kaye sutherland, Al WhitworthTurbo Productions - Graphic DesignerJanuary 1999  –  January 2003San FranciscoLevi Strauss & Co. - T-shirt Graphics / Clothing Graphics / Label DesignTeam members: Scott Greer, jeffrey levineSkillsProduct DesignLogo DesignGraphic DesignPackagingIllustratorGraphicsPhotoshopInDesignVisual CommunicationLayoutConcept DevelopmentArtCatalogsCorporate IdentityWeb DesignSee 5+MarketingArt DirectionBrochuresApparelBrand DevelopmentSee lessHow's this translation?Great•Has errorsThanks for your help!EducationCalifornia State University-ChicoBA, Visual CommunicationBA, Visual Communication1987  –  1992Visual Communications / Graphic DesignGroupsCSU, Chico Graphic Design AlumniEntrepreneur's NetworkOn Startups - The Community For EntrepreneursStart-Up Phase ForumView Scott’s full profile to...See who you know in commonGet introducedContact Scott directlyView Scott’s Full ProfileNot the Scott you’re looking for? View moreView this profile in another languageEnglishGermanPeople Also ViewedSue Chensalesperson at Taizhou Tianhe杨润杰深圳市宝安区沙井杰成五金配件经营部 - 模具制造Lorraine MadsenVice President of Sales at ColorprintGino SaccumanDirector of Sales, ColorprintShasta KrasniewiczBrand Manager at Deleon Realtyanna maria saccumanCasalinga presso me stessaAnna Morris-Owner of Skin Utopia & Licensed EstheticianPublic profile badgeInclude this LinkedIn profile on other websitesView profile badgesFind a different Scott GreerFirst NameLast NameExample:  Scott GreerScott GreerDirector of Sales at Horseshoe Bay ResortUnited StatesR. Scott GreerChairman of the Board at Calimmune, IncUnited StatesScott GreerOwner & Consultant at Greer Interactive, LLCUnited StatesScott GreerDale Carnegie Training - Instructor / AccountantUnited StatesScott GreerUnited StatesMore professionals named Scott GreerJobs similar to Scott’sCreative Services jobsLinkedIn member directory:abcdefghijklmnopqrstuvwxyzmoreBrowse members by country





























R. Scott Greer Joins Inogen Board Of Directors - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































R. Scott Greer Joins Inogen Board Of Directors






GlobeNewswire



Aug 6, 2015 8:45 AM EDT













 




























































 GOLETA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that R. Scott Greer has been appointed as an independent director to its Board of Directors, effective August 3, 2015. In addition, Mr. Greer was appointed to the Board's Audit Committee. He will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held on October 14, 2015. Mr. Greer fills the vacancy created by the resignation of Timothy Petersen. Mr. Petersen had served as a member of Inogen's Board since 2010.  Mr. Greer brings extensive executive and board level expertise to Inogen, as well as a passion for the advancement of innovative healthcare technologies. He is currently a director of Sientra, Inc. (Nasdaq:SIEN), as well as numerous biopharmaceutical companies including: Nektar Therapeutics (Nasdaq:NKTR), StemCells, Inc. (Nasdaq:STEM), and Versartis, Inc. (Nasdaq:VSAR). Previously, he was a director of Auspex Pharmaceuticals, Inc., Illumina, Inc., CV Therapeutics, Inc., Affymax, Inc., BAROnova, Inc., Chimeros, Inc., and Anaptys BioScience, Inc.  "Scott's 30 years of broad experience across various medical industries will be a valuable perspective on our Board of Directors," said Raymond Huggenberger, Inogen CEO. "He brings strengths in corporate governance and executive leadership. We look forward to his guidance as a member of our Board."  In addition to serving as Inogen's Chairman of the Board from 2005 to 2007, most recently he was Chairman of the Board of Ablexis from 2010 to 2015, Sirna Therapeutics from 2007 to 2009, and Abgenix from 2000 to 2006. Mr. Greer was Abgenix's CEO from 1996 to 2002. He also served as CFO and Senior Vice President of Corporate Development at Cell Genesys.  Mr. Greer has an M.B.A. from Harvard University and a B.A. in economics from Whitman College. He is a certified public accountant and worked as an auditor with Coopers & Lybrand.  



 








 










































If you liked this article you might like













Inogen (INGN) Showing Signs Of Being Strong And Under The Radar
Trade-Ideas LLC identified Inogen (INGN) as a strong and under the radar candidate



TheStreet Wire

Jul 7, 2016 10:15 AM EDT
























Today's Weak On High Volume Stock: Inogen (INGN)
Trade-Ideas LLC identified Inogen (INGN) as a weak on high relative volume candidate



TheStreet Wire

May 10, 2016 10:08 AM EDT
























3 Biotech Stocks With Charts to Watch -- And One Bonus Stock!
Three biotechs are among our four stocks showing strong technical momentum today.



Harry Boxer

Apr 16, 2016 11:00 AM EDT
























4 Momentum Stocks Worth Watching Right Now
A number of stocks we follow are showing strong technical momentum. Here are four to watch.



Harry Boxer

Apr 7, 2016 1:09 PM EDT








































 











Trending


Don't Sleep on General Electric's Cheap Stock Price


Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe


Rules For When It Seems Like Everything's Crashing: Cramer's 'Mad Money' Recap (Friday 7/21/17)


Microsoft's Surging Stock May Be Unstoppable


Microsoft Gets Rebooted Under CEO Satya Nadella -- Here Are His 6 Biggest Achievements











Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 












R. Scott Greer's House in Montecito, CA - Virtual Globetrotting
Virtual GlobetrottingSign In
                            or
                            Create an Account
                            to
                            Submit MapsBrowse MapsBy SourceGoogle MapsGoogle Maps Street ViewBing MapsBing Maps Birds Eye ViewSorted ByMost PopularTop RatedLatestTitle
                                    BuildingsBuildingsCastlesColleges / UniversitiesFamous ArchitectsFamous HomesHistoric HomesPalacesPrisonsSkyscrapersMore…StructuresAncientBridgesDomesIndianLandmarksMemorialsMonumentsTowersMore…EntertainmentAmphitheatresCarnivalsCasinosCircusDiningRoadside AttractionsTheme ParksWater ParksMore…SportsBaseball Fields (Pro)Baseball Fields (Other)BasketballFootball (Pro)Football (College)Hockey ArenasTennis StadiumsSoccer StadiumsMore…MilitaryMilitary BasesMilitary Air FieldsNavy / Coast GuardMilitary CommunicationsMissile SitesRadar SitesCovertCensored ImageryMore…TransportationAir PortsAutomotiveDrydocksHarborsLighthousesPiersRailSpaceportsMore…
                                    CelebsEntertainmentActorsMusiciansOther…BusinessBusinessGovernment & PoliticiansOther…SportsAuto RacingBaseballBasketballFootballGolfIce HockeySoccerTennisOther…
                                    Street ViewArtAdvertising / SignsGraffitiMuralsPaintingsSculptureMore…BuildingsCastlesGovernmentMuseumsNovelty / InterestingRetail / DiningMore…EntertainmentRoadside AttractionsStreet TheaterTheme Parks / Circuses / FairsRandom ObjectsOther…EventsConstructionFires / Crashes / DisastersHistoricalPeople Doing ThingsOther…NatureBirds / AnimalsParks / PlaygroundsScenicWeatherOther…VehiclesAirplanesCars / TrucksFire / Police / AmbulanceMilitary (Active)Military (On Display)More…
                                    OtherEventsAbandonedAccidentsIn The NewsMilitaryMovie LocationsMurder SitesOlympic SitesTV LocationsMore…LandArtwork - SculptureArtwork - Land ArtGolf CoursesMazesParksPollutionRacewaysZoosMore…NaturalGeographic ExtremesIslandsLakesMountainsParksRiversVolcanoesWaterfallsMore…TransportationAir - ClassicAir - Fighter JetsBoneyardsCruise ShipsFerriesRailShipwrecksSubmarinesMore…WorldUSR. Scott GreerR. Scott Greer's HouseMaps/R. Scott Greer's House  InfoNearby (403) 



Like





Tweet





+1





Pin





Talk









No Thumbnail 
             Google Maps  
             Birds Eye  




 

                    By jdubble07 @ 2010-04-29 15:13:05                




                    @
            

34.44939835,
                    -119.65236974

 

Montecito, California (CA), US 


R. Scott Greer is currently Managing Director of Numenor Ventures, LLC, where he has made direct investments in nearly twenty healthcare, technology, and consumer product companies.  Mr. Greer founded Abgenix, Inc., a biotechnology company focused on developing human antibody-based therapeutics.  He served as Abgenix's Chief Executive Officer from 1996 to 2002, and its Chairman from 2000 to 2006 when the company was acquired by Amgen, Inc. for approximately $2.2 billion.  Mr. Greer invested in and served as Chairman of the Board of Sirna Therapeutics, a publicly-traded biotechnology company that was sold to Merck for more than $1.1 billion in December 2006.  Prior to forming Abgenix, Mr. Greer spent five years at Cell Genesys, Inc., initially as Chief Financial Officer and Vice President of Corporate Development and later as Senior Vice President of Corporate Development.  Mr. Greer is currently Chairman of the Board of Acologix, Inc., a development-stage biotechnology company and in the past has served on the boards of numerous public and private life sciences companies.

                    Links: www.prnewswire.com 


                        1,420 views
                    
 

                    Unrated 



 

Categories

Buildings > Homes - Celebrity - Business 







Comments

Policies

                        Please log in if you don't want to post
                        anonymously (anonymous users cannot post links)
                    

Your Name





Comment






Please enter the Anti-Spam code  Reload 












 

Nearby Maps (50 km): 403 

Similar Maps: Homes - Celebrity - Business 


                Share:
            

 + My Favorites  Email 




Comments

Policies

                        Please log in if you don't want to post
                        anonymously (anonymous users cannot post links)
                    

Your Name





Comment






Please enter the Anti-Spam code  Reload 









 






	Anaptys Biosciences Inc Appoints R Scott Greer to Board of Directors













































Employer:
Login
Post Jobs


Job Seeker:
Login
Sign Up

























Search Life Sciences Jobs





Search Job Title Only












Radius:
Miles



Km80.5
















                 News | News By Subject | News by Disease |  
    News By Date | Search News



















Get Our FREEIndustry eNewsletter

email:


*
            
*
            



















 

 






Anaptys Biosciences, Inc. Appoints R. Scott Greer to Board of Directors  











Tweet








10/8/2007 10:10:15 AM


    LA JOLLA, Calif., Oct. 8 /PRNewswire/ -- Anaptys Biosciences, Inc., a privately-held biopharmaceutical product company, today announced the appointment of R. Scott Greer to the company's board of directors. Mr. Greer, a founder and former chairman and CEO of Abgenix, is a seasoned entrepreneur and executive with more than 20 years of experience in the biopharmaceutical industry.    "Scott Greer is a stellar addition to Anaptys' board," said Tom Smart, chairman and chief executive officer of Anaptys. "Scott's intimate knowledge of the therapeutic antibody space, combined with his impressive talent and track record for building and monetizing successful ventures, will bring invaluable perspective to the Anaptys team as we move toward commercialization of our novel technology and product portfolio."    Mr. Greer is a private investor and active consultant to the life sciences industry. He currently serves as managing director of Numenor Ventures, LLC. In 1996, he founded Abgenix, Inc., a biotechnology company focused on developing and commercializing human antibody based therapeutics, and served as its CEO from inception through 2002 and as its chairman from 2000 until 2006. In 2006, Abgenix was acquired by Amgen, Inc. in a cash transaction worth approximately $2.2 billion.    Mr. Greer also served as chairman of the board of Sirna Therapeutics, Inc. In 2007, Merck acquired Sirna for approximately $1.1 billion in cash.    "Anaptys is raising the bar for antibody-based therapeutics by addressing unsolved problems in protein selection and optimization," said Mr. Greer. "Their technology has true potential to revolutionize the field of therapeutic antibodies. I am excited to contribute to the leadership of this company during this time of significant progress and opportunity."    Prior to forming Abgenix, Mr. Greer spent five years at Cell Genesys, Inc., a biotechnology company, initially as chief financial officer and vice president of corporate development through its early development and initial public offering, and later as senior vice president of corporate development. Prior to Cell Genesys, Greer held various positions at Genetics Institute, Inc. (acquired by American Home Products Inc.), including director of corporate development.    Mr. Greer serves as chairman of Acologix, Inc., a development stage biotech company. He is also an investor in and chairman of Inogen, Inc., a commercial stage medical device company. Greer has held director roles at CV Therapeutics, Inc. Illumina, Inc., and Affymax, Inc., all now publicly traded biotech companies. In 2000, Mr. Greer was honored as Ernst & Young Entrepreneur of the Year (Northern California Life Sciences).    Mr. Greer holds a B.A. in economics from Whitman College and an M.B.A. from Harvard University. Prior to attending business school, Mr. Greer was a certified public accountant and auditor with Coopers & Lybrand.    About Anaptys Biosciences    Anaptys is a privately-held biopharmaceutical product company and the leader in the use of somatic hypermutation (SHM) for antibody discovery and protein optimization. The company's proprietary Omnitope-SHM(TM) System provides a robust platform for evolving and selecting optimized antibodies directed at validated, new, and previously intractable targets. This discovery platform leverages SHM, a natural process for generating antibody diversity, to rapidly and functionally select evolved proteins with enhanced bioactivities. Anaptys is pursuing multiple drug development programs with an initial focus on building a franchise of biologically synergistic product candidates. For more information, visit the company's web site at http://www.anaptysbio.com.CONTACT:  Bob Giargiari of GPR Global, +1-619-884-4410, for AnaptysBiosciences, Inc. Web site:  http://www.anaptysbio.com/ 






                Read at
                BioSpace.com







Related News
Anaptys Biosciences, Inc. Names Former XOMA (US) LLC (XOMA) Executive as Chairman and CEO  Duska Therapeutics, Inc. (DSKT.OB) Names Dr. James S. Kuo as Chief Executive Officer  Anaptys Biosciences, Inc. Acquires Key Intellectual Property for Novel Antibody Discovery and Protein Optimization Platform  Renovis, Inc. (RNVS) (Jobs) CEO Steps Down  GlaxoSmithKline (GSK) Names European Head Witty as New CEO  New CEO to Strengthen Moberg Derma's Organization  Biotech Giant Amgen (AMGN) (Jobs) to Cut 675 Thousand Oaks Jobs  Depomed, Inc. (DEPO) Cuts One-Fourth of Its Workforce  Onyx Pharmaceuticals, Inc. (ONXX) CEO to Retire  Pro-Pharmaceuticals, Inc. (PRW) Says CFO Resigns, Names Replacement  




Please enable JavaScript to view the comments powered by Disqus.
comments powered by Disqus






















                            •
                            BioSpace.com










                            •
                            AnaptysBio, Inc.




             
        





                            •
                            Biotech/Pharma - Personnel




             
        















                              
                            

                              
                             
                              
                            

                              
                            








                 
































Numenor Ventures, LLC







Home
Venture Capital/ Advisory Services
Human Resources Consulting
The Principals






R. Scott Greer
scott@numenorventures.com
Printable Version


R. Scott Greer, as managing director of Numenor Ventures, LLC, is a private investor in and consultant to the life sciences industry with over 35 years experience. Mr. Greer has made direct investments in over 25 healthcare, technology, and consumer product companies. He was a founder of Abgenix, Inc., a publicly traded biotechnology company focused on developing and commercializing human antibody based therapeutics, serving as its Chief Executive Officer from its inception in 1996 through 2002 and as its Chairman of the Board from 2000 until 2006. In 2006, Abgenix was acquired by Amgen, Inc. (Nasdaq: AMGN) for approximately $2.2 billion. Mr. Greer was  an investor in and Chairman of the Board of Sirna Therapeutics, a publicly traded biotechnology company that was sold to Merck for $1.1 billion in 2007. He was a director of and investor in Auspex Pharmaceuticals, a publicly traded specialty pharmaceuticals company, that was sold to Teva Pharmaceuticals for $3.5 billion in 2015.
Prior to forming Abgenix, Mr. Greer spent five years at Cell Genesys, Inc., a publicly traded biotechnology company, initially as Chief Financial Officer and Vice President of Corporate Development through its early development and initial public offering, and later as Senior Vice President of Corporate Development. Mr. Greer also held various positions at Genetics Institute, Inc., (acquired by American Home Products, Inc.). 
Mr. Greer is currently a director of several public biopharmaceutical and medical device companies including: Nektar Therapeutics (Nasdaq: NKTR), Versartis, Inc (Nasdaq: VSAR), Inogen, Inc. (Nasdaq: INGN),  and Sientra, Inc. (Nasdaq: SIEN). He is also Chairman of the Board of Calimmune, Inc., a private gene therapy company. In the past he was a director of Illumina, Inc. (Nasdaq: ILMN), CV Therapeutics, Inc. (Nasdaq: CVTX), StemCells, Inc. (Nasdaq: STEM), Affymax, Inc. (Nasdaq: AFFY), Auspex, Inc. (Nasdaq: ASPX), BAROnova, Inc., Chimeros, Inc., and Anaptys BioScience, Inc. He also served as Chairman of the Board of Inogen, Inc. and Ablexis, Inc.
Mr. Greer has a B.A. in economics from Whitman College and an M.B.A. from Harvard University. Prior to attending business school, Mr. Greer was an auditor with Coopers & Lybrand (now Pricewaterhouse Coopers, LLC) and was a certified public accountant. In 2000, Mr. Greer was honored as the Ernst & Young Entrepreneur of the Year (Northern California Life Sciences). 
Mr. Greer served on the board of the Santa Barbara Maritime Museum from 2003-2006.



Michelle Greer
michelle@numenorventures.com
Printable Version


“I have worked with dozens of other HR professionals. Michelle is, without a doubt, the top executive coach I have ever known.”
Jim Olson
        CEO, WestShore
        Management Group and  former CEO, SkyStream Networks
With more than 24 years of leadership experience in both Fortune 500 and start-up companies, Michelle Greer brings to each engagement keen insight, new ways of thinking, and a global perspective on issues rooted in real business needs. Her background spans across high tech to retail and lifestyle industries, where she has integrated business planning, talent and performance management, compensation strategies, and executive development into on-going organizational processes among multiple enterprises.
Michelle also has significant experience working with management teams of entrepreneurial companies, both in very early and more mature phases of the business.
Michelle has partnered with and coached successful CEO’s, CFO’s, and other executives to become even better at what they do, working with them to increase profitability through reducing costs, growing revenue, and getting the best out of their people.
Michelle also served on the boards of early-phase start-up companies and non-profits, where she has focused on advising executives on leadership, operational, and management issues.
Michelle served for six years as the Vice-President of Human Resources for SkyStream Networks in Sunnyvale, CA, where she built the entire HR function including compensation and benefits programs, executive compensation, stock programs, employee relations policies, management development, staffing processes, and organizational effectiveness. She worked with the executive team to consciously develop a culture and value system. She did extensive management and executive coaching in every area of the organization, attended all board meetings, and frequently presented to the Board. She also worked for 11 years at Agilent Technologies and the Hewlett Packard Company in several internal leadership roles, including Group HR manager, Santa Clara Site HR Manager, and Corporate Staffing manager.
She is a seasoned veteran of volatile business cycles. During the technology meltdown of 2001, for example, Michelle initiated and led workforce balancing programs which resulted in a company that not only survived but thrived through the downturn and retained key leaders and top employees while maintaining business goals.
Michelle is certified in the Meyers-Briggs Type Indicator, the Emotional Intelligence Inventory (EQi), and the PDI Profilor. She earned a masters degree in Counseling and Consulting Psychology from Harvard University and a bachelor’s degree in Psychology from Whitman College.


 michael kors outlet louis vuitton outlet sport blue 6s louis vuitton outlet sport blue 3s Louis Vuitton Outlet wolf grey 3s foamposites shooting stars sport blue 6s kate spade outlet sport blue 6s sport blue 6s michael kors outlet sport blue 3s michael kors outlet Louis Vuitton Outlet michael kors outlet thunder 14s Michael Kors Outlet michael kors outlet

   R. Greer | Numenor Ventures LLC | ZoomInfo.com









Greer R Scott - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1211703 - Address: C/o 420 South Fairview, Suite 200, Santa Barbara, CA 93117 11 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


P%ret213-0-27-118-4-0P%wins33331000675047 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



10/25/16 17:0010/24/16NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsGreer R ScottCADP20313.50331514121D-115-19-14-30-23-19-2-1-33-346
9/19/16 17:149/15/16NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsGreer R ScottCADM.d00.0020151898D3939522899-320-1-17-3416
11/13/15 17:3411/11/15VSARVersartis, Inc.DEHealthDrugPharmaceutical PreparationsGreer R ScottCADP10210.172106625D-49-34-41-13-11-11-7128-22-2424
10/19/15 17:0110/15/15NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsGreer R ScottCADM.d36911.3422336483D7-18-1-13-3-3-26-1122253940
1/27/15 19:241/27/15VSARVersartis, Inc.DEHealthDrugPharmaceutical PreparationsGreer R ScottCADP9517.254611011D-17-7-1-22-125-1-611-81-32
7/16/14 16:157/16/14ASPXAuspex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGreer R ScottCADP10019.25052607D
2/4/13 17:342/1/13NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsGreer R ScottCADM.d00.00981751D-21413-22771-12013183945
3/9/11 15:213/8/11NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsGreer R ScottCADM.d00.00143843D122-41-33-33-21-14-810011-9-41-17
7/8/05 19:067/6/05RNAISirna Therapeutics IncCOHealthDrugPharmaceutical PreparationsGreer R ScottCADP.d601.6003854107D
12/15/03 19:1912/12/03CVTXCv Therapeutics IncDEHealthBioPrdBiological Products, (No DiagGreer R ScottCADP13313.2501012518D
8/14/03 21:308/12/03RNAISirna Therapeutics IncCOHealthDrugPharmaceutical PreparationsGreer R ScottCODM1713.41050999%55D



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.







Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









﻿





Scottbrand - Error handling- 500 page


































Unexpected Error

                                        It looks like our system hit the sheets early and wasn't

                                        able to complete your request.
                                        Please try again.
                                    
RETURN TO THE HOMEPAGE









